Literature DB >> 17143322

Molecular regulation of HDL metabolism and function: implications for novel therapies.

Daniel J Rader1.   

Abstract

HDL metabolism represents a major target for the development of therapies intended to reduce the risk of atherosclerotic cardiovascular disease. HDL metabolism is complex and involves dissociation of HDL apolipoprotein and HDL cholesterol metabolism. Advances in our understanding of the molecular regulation of HDL metabolism, macrophage cholesterol efflux, and HDL function will lead to a variety of novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143322      PMCID: PMC1679714          DOI: 10.1172/JCI30163

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  124 in total

1.  High-density lipoproteins as an emerging therapeutic target for atherosclerosis.

Authors:  Daniel J Rader
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

2.  Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase.

Authors:  Cyrille Maugeais; Uwe J F Tietge; Uli C Broedl; Dawn Marchadier; William Cain; Mary G McCoy; Sissel Lund-Katz; Jane M Glick; Daniel J Rader
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

3.  The safety and immunogenicity of a CETP vaccine in healthy adults.

Authors:  Michael H Davidson; Kevin Maki; Denise Umporowicz; Alistair Wheeler; Charles Rittershaus; Una Ryan
Journal:  Atherosclerosis       Date:  2003-07       Impact factor: 5.162

4.  Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib.

Authors:  Ronald W Clark; Tamara A Sutfin; Roger B Ruggeri; Ann T Willauer; Eliot D Sugarman; George Magnus-Aryitey; Patricia G Cosgrove; Thomas M Sand; Ronald T Wester; John A Williams; Michael E Perlman; Mark J Bamberger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-22       Impact factor: 8.311

5.  Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

Authors:  A S Plump; C J Scott; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

6.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Authors:  Steven E Nissen; Taro Tsunoda; E Murat Tuzcu; Paul Schoenhagen; Christopher J Cooper; Muhammad Yasin; Gregory M Eaton; Michael A Lauer; W Scott Sheldon; Cindy L Grines; Stephen Halpern; Tim Crowe; James C Blankenship; Richard Kerensky
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

7.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Authors:  D J Rader; K Ikewaki; N Duverger; H Schmidt; H Pritchard; J Frohlich; M Clerc; M F Dumon; T Fairwell; L Zech
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells.

Authors:  Scott D Covey; Monty Krieger; Wei Wang; Marsha Penman; Bernardo L Trigatti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-26       Impact factor: 8.311

9.  Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  Wenwu Zhang; Patricia G Yancey; Yan Ru Su; Vladimir R Babaev; Yuomin Zhang; Sergio Fazio; MacRae F Linton
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

Review 10.  Transcriptional control of apolipoprotein A-I gene expression in diabetes.

Authors:  Arshag D Mooradian; Michael J Haas; Norman C W Wong
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  194 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 2.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

3.  Impact of self-association on function of apolipoprotein A-I.

Authors:  Shobini Jayaraman; Sumiko Abe-Dohmae; Shinji Yokoyama; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

4.  Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice.

Authors:  Eric T Alexander; Charulatha Vedhachalam; Sandhya Sankaranarayanan; Margarita de la Llera-Moya; George H Rothblat; Daniel J Rader; Michael C Phillips
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

5.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

6.  Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles.

Authors:  John B Massey; Henry J Pownall; Stephen Macha; Jamie Morris; Matthew R Tubb; R A Gangani D Silva
Journal:  J Lipid Res       Date:  2009-01-28       Impact factor: 5.922

7.  Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.

Authors:  Mao Koyama; Masafumi Tanaka; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

8.  Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1.

Authors:  Jian Zhu; Joseph Gardner; Clive R Pullinger; John P Kane; John F Thompson; Omar L Francone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

9.  Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

Review 10.  Synthetic high-density lipoprotein-like nanoparticles for cancer therapy.

Authors:  Linda Foit; Francis J Giles; Leo I Gordon; Colby Shad Thaxton
Journal:  Expert Rev Anticancer Ther       Date:  2014-12-09       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.